Reneural Technologies builds a comprehensive neurorehabilitation platform that integrates virtual reality (VR), robotics, electromyography (EMG) and functional electrical stimulation (FES). The platform targets physical, visual, cognitive and mental-health therapies in a single, cohesive system to provide personalised long-term care. It is designed to improve patient outcomes, reduce healthcare costs and ease the burden on clinicians by supporting remote care. Led by CEO Victor Harabari, the company focuses on closing gaps in continuous rehabilitation for stroke survivors. Reneural plans to use new funding to grow its VR therapy offerings and to expand into mental-health support for stroke survivors. The company was formerly known as CardioCrown and is based in Hatfield, UK.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2024